General Urology

Promising results in California, but antibacterial resistance still a concern

Almost half of patients in active surveillance avoided cystectomy during 40 months of follow-up

Health news and commentary gathered by MedPage Today staff

New treatments reshape metastatic and muscle-invasive bladder cancer therapy

Patients with complete response can have long treatment-free interval, study suggests

Other IKCS news: closer look at belzutifan safety, challenges of triplet therapies for RCC

Possible guidance for use of adjuvant immunotherapy in high-risk, non-metastatic disease

Better OS, PFS, response rate, but newer combination strategies not included

More IKCS news: Long-term survival benefit with nivolumab/ipilimumab, disease-slowing surgery

Low rate of recurrence with surgery or nonsurgical options, but data can inform decisions

Confirmed responses in one-fourth to one-third of patients with refractory disease

And nearly half of responders to enfortumab vedotin plus pembrolizumab remained in remission

Meta-analysis finds one most effective option to prevent symptomatic episodes

Study also raises question of antibiotic prophylaxis in kids with common congenital anomaly